In studies on the relation between indoor mold exposure and symptoms/disease, the exposure should be described in terms of biomass and not viability. This paper reviews field studies in which (1 --3)-P-D-glucan was measured as a marker of biomass and was related to the extent of symptoms and measures of inflammation among exposed subjects. Increased levels of (1 ->3)-n-D-glucan were related to an increased extent of symptoms and markers of inflammation. The data suggest that (1 --3 
Background
Effects related to indoor air have been reported in a large number of studies from different countries (1, 2) . The major symptoms are irritation in the eyes, nose and throat; dry cough; fatigue/headache; and skin problems, all of which can be caused by nonspecific airway inflammation (3) .
Many studies show a relationship between symptoms and a history of dampness or flooding of buildings (4) . Humidity in building structures favors the growth of fungi and certain bacteria. These microorganisms contain several agents with important biologic properties, such as endotoxin, mycotoxins, (1 ->3)-P-D-glucan, and different allergens that can cause a variety of toxicologic and immunologic effects (5) . Although the development of an infection requires that the organism be viable, these effects do not require viability. Risk estimations based on viability are thus not relevant, and indicators of cell biomass or measures of the specific toxic agent should be used.
Several agents in microbes have been used to determine biomass. Endotoxin is widely used for the estimation of Gramnegative bacteria (6) . Ergosterol has been used to determine fungal biomass (7).
(1--3)-P-D-glucan, a polyglucose compound present in the cell wall of fungi, certain bacteria and vegetable materials, has also been used (8) .
A number of studies have used measurements of airborne (1--3)-f3-D-glucan to estimate mold exposure and to evaluate the relation with effects present in the exposed populations. A review of these studies is presented in the following sections, preceded by a description of the analytical methods for determination of In the studies described in this paper, the air samples were taken using aggressive sampling. We used a device stirring up the air from the floor using an air stream, which is passed over the surface of the room in which the sampling is performed. Without this procedure, the dust (and mold) particles will rapidly set on the floor surface and air sampling would give a false negative value in environments where there is no or little movement of persons. Alternatives are to sample over a prolonged period, e.g., 8 hr during periods of normal movement in the room or to use a personal sampler.
Studies Performed
The first published study reported an investigation of a number of flats in a small town in Sweden (11) . The presence of symptoms was evaluated using questionnaires, and measurements of (1 -*3)-P-D-glucan were made in the houses. The The symptoms disappeared when the boys moved out of the house. About a year later, the parents developed airway inflammation and they were also forced to move from the house. A similar case history was reported in Sweden (14) . In this study, three children reported intense symptoms of airway inflammation and fatigue/headache. Two of the children were on medication with bronchodilators. Levels of (W1-3)-P-Dglucan ranged from 21.8 to 1 15.2 ng/m3 in different rooms of the house. The children finally moved to their grandmother's house, and the symptoms cleared within a few months. These case studies demonstrate that children living in home environments with molds may develop severe airway symptoms as well as fatigue and headache. Except for the sensitization to mites in one child, no evidence of allergic reactions was present. The rapid improvement in both cases when the children moved out of their homes supports a hypothesis of causality.
One study was performed in a day-care center with a history of dampness (15) .
For several years, symptoms of nasal swelling, throat irritation, headache, and fatigue had been reported by the staff. The 15 staff members were investigated by questionnaire, and a methacholine test was performed to determine airway responsiveness. A few months later, the center was closed for renovation and the personnel worked elsewhere. After the renovation, they returned to the center and were examined 1 and 2 years later.
The amount of airborne (1->3)-P-Dglucan before the renovation was 11.4 ng/m3 (n= 24, SD = 2.3) and 1.3 ng/m3 (n = 13, SD = 0.9, p < 0.0001) after the renovation. The results of measurements of airway responsiveness (Table 2) showed that there was a tendency for the average A follow-up study was made with volunteers from the rowhouse study (17) . A blood sample was taken and blood monocytes were isolated for determination of cytokine production before and after in vitro cell stimulation. After comparing persons with an increased level of (1->3)-P-D-glucan in their homes with those in homes with low or undetectable levels, an increased baseline production of tumor necrosis factor a was found.
Several studies have investigated the children's environments. In an investigation in Sweden, two schools-one with mold problems and another without problems-were studied (18) . The extent of respiratory symptoms was significantly higher in the school with higher levels of (1->3)-P-D-glucan (15.3 ng/m3) than in the school with low levels (2.9 ng/m3). Among atopic children, the extent of symptoms of dry cough, cough with phlegm, and hoarseness was similar to those of the nonatopics in the low (1-*3)-fP-D-glucan school but significantly more common in the high (1--3)-P-D-glucan school. Comments A general conclusion from the studies reviewed here is that there was a relation between exposure to (1 ->3)-P-D-glucan as an indicator of mold biomass and the extent of symptoms of airway inflammation, fatigue, and headache. Some data show that objective measurements of inflammation were also related to the exposure. In some of the studies, dose-response relationships could be demonstrated. For field measurements, (1 -*3)-P-D-glucan may thus be a suitable indicator of risk.
Even if there is a relation between indoor air effects and the amount of (1->3)-fB-D-glucan, this cannot be taken as evidence for a causal relationship. (1 -*3)-n-D-glucan is an indicator of fungal biomass, but fungi contain a variety of agents with biologic effects. Support for causality would require exposures to isolated (1 ->3)-P-Dglucan, preferably using atopic and asthmatic subjects. Although a few such studies have been reported and have confirmed an effect on the airways (19) , there is still a great need for further research in that area.
